Live feed
Filing
SC 13D
SC 13D0001493152-21-015766·PROVECTUS BIOPHARMACEUTICALS, INC.
Schedule 13D ownership disclosure
PROVECTUS PHARMACEUTICAL INCORPORATED
Security class unavailable · CUSIP: 74373P108
Event date: 2021-06-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 21,032,058
- Percent of class
- 5.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-21-015766
- Form type
- SC 13D
- Filer
- PROVECTUS BIOPHARMACEUTICALS, INC.
- CIK
- CIK 315545
- Filed
- Jun 30, 2021
- Reporting period
- Jun 20, 2021
- Description
- Schedule 13D beneficial ownership